Philip B. Verghese

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.472Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Associations of sleep duration and daytime sleepiness with plasma amyloid beta and cognitive performance in cognitively unimpaired, middle-aged and older African Americans

SLEEP(2023)10.1093/sleep/zsad302

Top 40%

0.472DataRank

Top 40%10 citations

Ammara Malik, David T. Plante, Derek Norton, Rebecca L. Koscik, Lianlian Du +15 more

Papers

Driven by 16 papers — median percentile 60. Top paper: “Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial”.

Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial

Alzheimer s & Dementia(2024)10.1002/alz.13803

N/A

1.1DataRank · unranked

40 citations

Rema Raman, Andy Liu, Oliver Langford, Keith A. Johnson, Leona K. Shum +14 more

Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid

Alzheimer s & Dementia(2024)10.1002/alz.13764

N/A

0.717DataRank · unranked

118 citations

Kristopher M. Kirmess, Stephanie Eastwood, Traci L. Wente‐Roth, Faith Irvin, Mary S. Holubasch +20 more

Associations of sleep duration and daytime sleepiness with plasma amyloid beta and cognitive performance in cognitively unimpaired, middle-aged and older African Americans

SLEEP(2023)10.1093/sleep/zsad302

Top 40%

0.472DataRank

Top 40%10 citations

Ammara Malik, David T. Plante, Derek Norton, Rebecca L. Koscik, Lianlian Du +15 more

Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals

Alzheimer s & Dementia(2025)10.1002/alz.70625

N/A

0.428DataRank · unranked

6 citations

Heather J. Wiste, Terry M. Therneau, Michael Griswold, Niklas Mattsson, Sebastian Palmqvist +20 more

Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients

Annals of Neurology(2024)10.1002/ana.27027

N/A

0.330DataRank · unranked

8 citations

Suzanne E. Schindler, Amber Salter, Dana C. Perantie, Nicole Shelley, Bradley Judge +14 more

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam)

PLoS ONE(2024)10.1371/journal.pone.0302998

N/A

0.319DataRank · unranked

4 citations

José A. Luchsinger, Gabriel C. Léger, Curtis Taylor, Diane M. Jacobs, David P. Salmon +15 more

Racial and ethnic differences in plasma p‐tau217 ratio biomarker eligibility rates in a preclinical AD trial with lecanemab

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2025)10.1002/dad2.70164

N/A

0.208DataRank · unranked

3 citations

Rema Raman, Andy Liu, Oliver Langford, Joel B. Braunstein, Philip B. Verghese +10 more

Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairment

npj Dementia(2025)10.1038/s44400-025-00026-y

N/A

0DataRank · unranked

1 citations

Tim West, Kris Kirmess, I. Fogelman, Sutapa Ray, Philip B. Verghese +4 more

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Molecular Neurodegeneration(2021)10.1186/s13024-021-00451-6

N/A

0DataRank · unranked

233 citations

Kristopher M. Kirmess, Matthew R. Meyer, Mary S. Holubasch, S Knapik, Yan Hu +10 more

Implementation of an Alzheimer’s Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center Study

Journal of Personalized Medicine(2025)10.3390/jpm15100469

N/A

0DataRank · unranked

0 citations

Robert M. Carlile, Kim G. Johnson, Darren R. Gitelman, Lawren VandeVrede, Demetrius M. Maraganore +7 more

The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis

Clinica Chimica Acta(2021)10.1016/j.cca.2021.05.011

N/A

0DataRank · unranked

134 citations

Matthew R. Meyer, Mary S. Holubasch, S Knapik, Yan Hu, Erin N. Jackson +8 more

Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA‐FAIM cohort

Alzheimer s & Dementia Translational Research & Clinical Interventions(2023)10.1002/trc2.12414

N/A

0DataRank · unranked

3 citations

Carol A. Van Hulle, Rebecca Langhough, Derek Norton, Megan Zuelsdorff, Diane C. Gooding +19 more

PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology

Diagnostics(2024)10.3390/diagnostics14161739

N/A

0DataRank · unranked

14 citations

Matthew R. Meyer, Kristopher M. Kirmess, Traci L. Wente‐Roth, Faith Irvin, Mary S. Holubasch +6 more

Clinical Utility of an Alzheimer’s Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study

Diagnostics(2025)10.3390/diagnostics15020167

N/A

0DataRank · unranked

9 citations

Demetrius M. Maraganore, Robert M. Carlile, Kim G. Johnson, David A. Merrill, Darren R. Gitelman +9 more

Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementia

Alzheimer s & Dementia(2025)10.1002/alz.14570

N/A

0DataRank · unranked

8 citations

Lianlian Du, Rachel Studer, Erin M. Jonaitis, Sanjay Asthana, Bradley T. Christian +11 more

Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET

Alzheimer s & Dementia(2025)10.1002/alz.14629

N/A

0DataRank · unranked

5 citations

Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, Michael Griswold, Joel B. Braunstein +13 more

Philip B. Verghese

Indexed papers

Top data-sharing exemplar

Papers